Feb 21 |
Autolus Therapeutics plc's (NASDAQ:AUTL) institutional investors lost 8.1% last week but have benefitted from longer-term gains
|
Feb 15 |
Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year?
|
Feb 12 |
Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength?
|
Feb 8 |
Autolus prices underwritten offering to raise $350M to fund development of obe-cel program
|
Feb 8 |
BioNTech to invest $200M in Autolus as part of a CAR-T deal
|
Feb 8 |
Autolus Announces Pricing of Underwritten Offering
|
Feb 8 |
BioNTech partners with Autolus to boost cell therapy manufacturing
|
Feb 8 |
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
|
Feb 6 |
Autolus Upgrades Leadership And Faces CAR-T Approval
|
Feb 1 |
2seventy bio, Inc. (TSVT) Surges 28.2%: Is This an Indication of Further Gains?
|